Pellosi DS - Search Results

1

β-cyclodextrin nanosponges as multifunctional ingredient in water-containing semisolid formulations for skin delivery.

Conte C, Caldera F, Catanzano O, D'Angelo I, Ungaro F, Miro A, Pellosi DS, Trotta F, Quaglia F. Conte C, et al. Among authors: pellosi ds. J Pharm Sci. 2014 Dec;103(12):3941-3949. doi: 10.1002/jps.24203. Epub 2014 Oct 16. J Pharm Sci. 2014. PMID: 25322671

2

In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery.

Pellosi DS, d'Angelo I, Maiolino S, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Quaglia F, Ungaro F. Pellosi DS, et al. Eur J Pharm Biopharm. 2018 Sep;130:30-38. doi: 10.1016/j.ejpb.2018.06.006. Epub 2018 Jun 19. Eur J Pharm Biopharm. 2018. PMID: 29890256

3

Polymeric Nanoparticles for Cancer Photodynamic Therapy.

Conte C, Maiolino S, Pellosi DS, Miro A, Ungaro F, Quaglia F. Conte C, et al. Among authors: pellosi ds. Top Curr Chem. 2016;370:61-112. doi: 10.1007/978-3-319-22942-3_3. Top Curr Chem. 2016. PMID: 26589506 Review.

4

Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.

Russo A, Pellosi DS, Pagliara V, Milone MR, Pucci B, Caetano W, Hioka N, Budillon A, Ungaro F, Russo G, Quaglia F. Russo A, et al. Among authors: pellosi ds. Int J Pharm. 2016 Sep 10;511(1):127-139. doi: 10.1016/j.ijpharm.2016.06.118. Epub 2016 Jun 29. Int J Pharm. 2016. PMID: 27374195

5

Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells.

Pellosi DS, Calori IR, de Paula LB, Hioka N, Quaglia F, Tedesco AC. Pellosi DS, et al. Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:1-9. doi: 10.1016/j.msec.2016.09.064. Epub 2016 Sep 28. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 27987651

6

Pluronic^® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.

Pellosi DS, Moret F, Fraix A, Marino N, Maiolino S, Gaio E, Hioka N, Reddi E, Sortino S, Quaglia F. Pellosi DS, et al. Int J Nanomedicine. 2016 Sep 6;11:4479-4494. doi: 10.2147/IJN.S103344. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27660441 Free PMC article.

7

Magneto low-density nanoemulsion (MLDE): A potential vehicle for combined hyperthermia and photodynamic therapy to treat cancer selectively.

Pellosi DS, Macaroff PP, Morais PC, Tedesco AC. Pellosi DS, et al. Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:103-111. doi: 10.1016/j.msec.2018.06.033. Epub 2018 Jun 20. Mater Sci Eng C Mater Biol Appl. 2018. PMID: 30184726

8

Spotlight on the delivery of photosensitizers: different approaches for photodynamic-based therapies.

Pellosi DS, De Jesus PDCC, Tedesco AC. Pellosi DS, et al. Expert Opin Drug Deliv. 2017 Dec;14(12):1395-1406. doi: 10.1080/17425247.2017.1307337. Epub 2017 Mar 27. Expert Opin Drug Deliv. 2017. PMID: 28291372 Review.

9

Light source is critical to induce glioblastoma cell death by photodynamic therapy using chloro-aluminiumphtalocyanine albumin-based nanoparticles.

Davanzo NN, Pellosi DS, Franchi LP, Tedesco AC. Davanzo NN, et al. Among authors: pellosi ds. Photodiagnosis Photodyn Ther. 2017 Sep;19:181-183. doi: 10.1016/j.pdpdt.2017.04.017. Epub 2017 May 29. Photodiagnosis Photodyn Ther. 2017. PMID: 28571728

10

Prodrugs for targeted cancer therapy.

Souza C, Pellosi DS, Tedesco AC. Souza C, et al. Among authors: pellosi ds. Expert Rev Anticancer Ther. 2019 Jun;19(6):483-502. doi: 10.1080/14737140.2019.1615890. Epub 2019 May 13. Expert Rev Anticancer Ther. 2019. PMID: 31055990 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters